Zoloft Linked to Severe Birth Defects

The FDA issued a Public Health Advisory regarding the widely used antidepressant medication Zoloft in July 2006 and warned if women took Zoloft during pregnancy, the exposure posed a serious risk to the fetus and was linked to an increased risk of congenital heart defects.

Medical studies show the use of Zoloft use during pregnancy has been associated with the following severe birth defects:

• Atrial or Ventricular Septal Defect
• Congenital Heart Defects (Tetralogy of Fallot, Hypoplastic Left Heart Syndrome, etc.)
• Abdominal Birth Defects (Omphalocele, Gastroschisis)
• Cranial Birth Defects (Craniosynostosis, Hydrocephalus)
• Lung Birth Defects, including Persistent Pulmonary Hypertension in babies (PPHN)
• Spina Bifida
• Cleft lip/ palate
• Club foot

Zoloft is the brand version of the prescription depression medication setraline. Zoloft was released by Pfizer in 1992, and safety updates indicate serious concerns about the use of Zoloft during any part of pregnancy, including in the first trimester. Furthermore, clinical trials show an association between the use of Zoloft during pregnancy and increased risks of congenital birth defects in fetuses.

If you or a loved one took Zoloft during pregnancy and the baby was born with a severe birth defect, the family and child may be entitled to financial compensation to help with medical costs, future surgeries, physical therapy, special education needs, lost wages and other expenses.

Contact AkinMears, G.P. today for a free legal consultation. Complete the contact form on the right side of this page, or call toll free 877-534-5750, 24 hours per day, 7 days a week for assistance.